Latest News

People with type 2 diabetes are at increased risk of Alzheimer's disease and other adverse cognitive health issues. A new study conducted at by Umeå University, Sweden, shows that the reason for the correlation may be that people with type 2 diabetes have more difficulty getting rid of a protein that potentially increases the likelihood of contracting the disease.

A new Journal of Alzheimer's Disease article unveils an innovative tool demonstrating how key sectors and technologies can positively impact people living with dementia. The article provides a visual summary of dementia best practices from around the world in one compact tool for everyone in the dementia ecosystem—including people living with dementia; their family, friends, and communities; policymakers, employers, health system leaders, clinicians, social services providers, educators; researchers, technology entrepreneurs, and investors.

With the advent of new omics technologies in recent years, there has been a deluge of complex, high-dimensional data on Alzheimer’s disease (AD). A topical collection of articles on omics approaches in AD research in a supplement to the Journal of Alzheimer’s Disease (JAD), published by IOS Press, provides new insights into altered pathways and disease-related processes, increasing our understanding of AD pathogenesis to identify specific biomarkers of disease status, progression, and therapeutic response.